LMR Partners’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | – | – | 1108 |
|
|
2025
Q1 | – | Sell |
-3,724
| Closed | -$453K | – | 1100 |
|
|
2024
Q4 | $453K | Sell |
3,724
-41,903
| -92% | -$5.09M | ﹤0.01% | 485 |
|
|
2024
Q3 | $5.7M | Sell |
45,627
-15,217
| -25% | -$1.9M | 0.05% | 177 |
|
|
2024
Q2 | $9.61M | Buy |
+60,844
| New | +$9.61M | 0.08% | 129 |
|
|
2024
Q1 | – | Sell |
-22,654
| Closed | -$2.18M | – | 966 |
|
|
2023
Q4 | $2.18M | Buy |
+22,654
| New | +$2.18M | 0.02% | 229 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 863 |
|
|
2023
Q2 | – | Sell |
-44,479
| Closed | -$6.13M | – | 992 |
|
|
2023
Q1 | $6.13M | Buy |
44,479
+25,389
| +133% | +$3.5M | 0.1% | 211 |
|
|
2022
Q4 | $2.47M | Sell |
19,090
-4,449
| -19% | -$577K | 0.04% | 451 |
|
|
2022
Q3 | $2.6M | Sell |
23,539
-90,121
| -79% | -$9.96M | 0.05% | 425 |
|
|
2022
Q2 | $8.52M | Buy |
113,660
+51,901
| +84% | +$3.89M | 0.14% | 162 |
|
|
2022
Q1 | $4.83M | Buy |
+61,759
| New | +$4.83M | 0.06% | 327 |
|
|
2021
Q3 | – | Sell |
-5,997
| Closed | -$466K | – | 1175 |
|
|
2021
Q2 | $466K | Buy |
+5,997
| New | +$466K | 0.01% | 693 |
|
|
2021
Q1 | – | Sell |
-51,986
| Closed | -$8.86M | – | 1050 |
|
|
2020
Q4 | $8.86M | Buy |
+51,986
| New | +$8.86M | 0.14% | 71 |
|
|
2019
Q3 | – | Sell |
-19,359
| Closed | -$2.94M | – | 507 |
|
|
2019
Q2 | $2.94M | Sell |
19,359
-7,267
| -27% | -$1.1M | 0.11% | 91 |
|
|
2019
Q1 | $3.17M | Buy |
+26,626
| New | +$3.17M | 0.16% | 93 |
|
|
2018
Q4 | – | Sell |
-37,216
| Closed | -$6.01M | – | 468 |
|
|
2018
Q3 | $6.01M | Sell |
37,216
-59,929
| -62% | -$9.68M | 0.38% | 68 |
|
|
2018
Q2 | $12.8M | Buy |
+97,145
| New | +$12.8M | 0.67% | 27 |
|